Just covered at $40. This moron just made 35% in a month. Hope to have another chance to re-established positions in the high 50s or low 60s again.Having fun can still mean being a moron. As all guys personally know! LOL.
If you bought and sold after the pump you would have made a lot more. Enjoy your crumbs.Just covered at $40. This moron just made 35% in a month. Hope to have another chance to re-established positions in the high 50s or low 60s again.
Or I buy right after the run up and now lose 40%. Give me the crumbs.If you bought and sold after the pump you would have made a lot more. Enjoy your crumbs.![]()
Scaredy cat.Or I buy right after the run up and now lose 40%. Give me the crumbs.
Came in hot.June inflation data tomorrow. The expectation game begins!
Definitely hot, but with clear signs that transitory market segments are leading the way (like used cars and trucks). Not too much of a negative reaction, but we will see what happens tomorrow.
Slightly green in premarket.Definitely hot, but with clear signs that transitory market segments are leading the way (like used cars and trucks). Not too much of a negative reaction, but we will see what happens tomorrow.
As do WFC and Citi.
I'm not a health care guy but, MS has a $33 price target.Any of you health care guys have an opinion on Organon? (OGN). It spun off from Merck a few months ago. I'm trying to decide whether to increase it to 1-2% of my portfolio or cut it and can't really find anyone else's research on it.
OGN is in a good space, but not a high growth space (in terms of pharma). Individual companies are so unpredictable due to clinical trials and FDA decisions. I love pharma/biotech, but for me, the play is a fund/etf. The only HC stock I own is the s-ton of my own company's via their LTI/RSU comp program.Any of you health care guys have an opinion on Organon? (OGN). It spun off from Merck a few months ago. I'm trying to decide whether to increase it to 1-2% of my portfolio or cut it and can't really find anyone else's research on it.
I'm the complete opposite. Pharma stocks are the ultimate "buy it and forget about it" for me. I bought the Merck shares after the Vioxx issue about 15 years ago and reinvested every dividend. My cost basis is about $18.50 and it pays a 14% yield on that original cost basis. Once I'm done working I'll just start spending the dividends instead of reinvesting them.OGN is in a good space, but not a high growth space (in terms of pharma). Individual companies are so unpredictable due to clinical trials and FDA decisions. I love pharma/biotech, but for me, the play is a fund/etf. The only HC stock I own is the s-ton of my own company's via their LTI/RSU comp program.
My PRHSX has returned 19.32% per year over the past 10 years and 16.83% over the past 15 years. Now that is set it and forget it!I'm the complete opposite. Pharma stocks are the ultimate "buy it and forget about it" for me. I bought the Merck shares after the Vioxx issue about 15 years ago and reinvested every dividend. My cost basis is about $18.50 and it pays a 14% yield on that original cost basis. Once I'm done working I'll just start spending the dividends instead of reinvesting them.
yeah, i really should dig into their cashflows and business, but I was kinda hoping someone here already did all that work for me. LOLOGN hasn't declared a dividend yet. Until you know what they will be paying as a non-high grower you're essentially guessing with a lot less than 100% information.
yeah, i really should dig into their cashflows and business, but I was kinda hoping someone here already did all that work for me. LOL
This may be difficult, since it's a new business entity.yeah, i really should dig into their cashflows and business, but I was kinda hoping someone here already did all that work for me. LOL
The market is really not in party mode any more though. More like just a bunch of people hanging out.Party on!
Federal Reserve Chairman Jerome Powell said Wednesday the economy is “a ways off” from where it needs to be for the central bank to change policy.
“Conditions in the labor market have continued to improve, but there is still a long way to go,” he said, adding that inflation has “increased notably” due mostly to temporary factors.
The market is definitely confused. It has been meandering for the past few weeks. Earnings have been amazing, which normally wins the day.The market is really not in party mode any more though. More like just a bunch of people hanging out.
I think the market is probably a little wary of inflation being a more consistent threat then Powell is letting on.
Yet the 10yr is down a bit again this morning. So I don't know what that is trying to say. But the inflation narrative is definitely getting louder.
The market is still pretty expensive. But instead of an overall correction(we have seen sectors correct under the surface) it meanders while these big earnings grow into their multiples.The market is definitely confused. It has been meandering for the past few weeks. Earnings have been amazing, which normally wins the day.
#transatory!Haven't checked in awhile but Lumber is down to $520. Which is 65ish% off it's highs. Lowest levels since last Nov.
Precovid lumber was at $460.
So near normal.
Not sure how long this takes to work it's way to the retail end of it all(still hearing about $80 plywood).
I'll sign up for meandering instead of correcting. Also, indexes have done very well as compared to sectors or types of stocks. There seems to a constant churn under the surface, but so far, the main indexes keep going up.The market is still pretty expensive. But instead of an overall correction(we have seen sectors correct under the surface) it meanders while these big earnings grow into their multiples.
Eventually the market will look pretty reasonable, at which point a big earnings qtr will lead to a big market jump.
That's how I'm seeing it anyways.
Or I buy right after the run up and now lose 40%. Give me the crumbs.
I covered that too early at 190. Only made 25%.Or you could have jumped into GME last Tuesday when it broke below 200 and only lost 20%.
Oil had been heading down for the past week or so. OPEC made a deal, so Cramer is probably right.Cramer called a top in oil, something about a million more barrels in the permian, and that will outpace the demand.
Would be another welcome move to help cool inflation.
They still have to follow securities lawsThis may be difficult, since it's a new business entity.
But there is no track record for the new entity and it's business performance.They still have to follow securities laws
But there is no track record for the new entity and it's business performance.
You're entirely wrong - go click on links johnny posted. UnbelievableNope.
Nope. New company, new basket of products, new leadership team without support from the broader company, future biosims that are unproven. They try to make it look like they have a long track record, but that's completely BS.You're entirely wrong - go click on links johnny posted. Unbelievable